CH513907A - Verfahren zur Herstellung neuer Thiazolderivate - Google Patents
Verfahren zur Herstellung neuer ThiazolderivateInfo
- Publication number
- CH513907A CH513907A CH434369A CH434369A CH513907A CH 513907 A CH513907 A CH 513907A CH 434369 A CH434369 A CH 434369A CH 434369 A CH434369 A CH 434369A CH 513907 A CH513907 A CH 513907A
- Authority
- CH
- Switzerland
- Prior art keywords
- production
- thiazole derivatives
- new thiazole
- new
- derivatives
- Prior art date
Links
- 150000007979 thiazole derivatives Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F1/00—Compounds containing elements of Groups 1 or 11 of the Periodic Table
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH806271A CH513910A (de) | 1968-03-22 | 1969-03-21 | Verfahren zur Herstellung neuer Thiazolderivate |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB03989/68A GB1192701A (en) | 1968-03-22 | 1968-03-22 | Novel Thiazole Derivatives, the preparation thereof and Compositions containing the same |
Publications (1)
Publication Number | Publication Date |
---|---|
CH513907A true CH513907A (de) | 1971-10-15 |
Family
ID=10033003
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH806371A CH553209A (de) | 1968-03-22 | 1969-03-21 | Verfahren zur herstellung neuer (alpha)-thiazolyl-(alpha)-alkylmalonsaeureester. |
CH434369A CH513907A (de) | 1968-03-22 | 1969-03-21 | Verfahren zur Herstellung neuer Thiazolderivate |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH806371A CH553209A (de) | 1968-03-22 | 1969-03-21 | Verfahren zur herstellung neuer (alpha)-thiazolyl-(alpha)-alkylmalonsaeureester. |
Country Status (15)
Country | Link |
---|---|
US (1) | US3661920A (de) |
AT (1) | AT284841B (de) |
BE (1) | BE730284A (de) |
BR (1) | BR6807374D0 (de) |
CA (1) | CA948199A (de) |
CH (2) | CH553209A (de) |
CS (3) | CS154267B2 (de) |
DE (1) | DE1913472A1 (de) |
DK (3) | DK125251B (de) |
ES (1) | ES365089A1 (de) |
FR (1) | FR2004544A1 (de) |
GB (1) | GB1192701A (de) |
IE (1) | IE32967B1 (de) |
IL (1) | IL31679A (de) |
NL (1) | NL6903963A (de) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2703542C2 (de) * | 1977-01-26 | 1985-09-26 | Schering AG, 1000 Berlin und 4709 Bergkamen | Thiazolylzimtsäurenitrile, Insektenbekämpfungsmittel enthaltend diese Verbindungen sowie Verfahren zu ihrer Herstellung |
US4197306A (en) * | 1977-06-30 | 1980-04-08 | Uniroyal, Inc. | Aryl-substituted thiazoles |
US4153703A (en) * | 1977-06-30 | 1979-05-08 | Uniroyal, Inc. | Method of controlling insects and acarids with certain aryl-substituted thiazoles |
DE2801794A1 (de) | 1978-01-17 | 1979-07-19 | Basf Ag | Verfahren zur herstellung von thiazolderivaten und neue thiazole |
DE2920183A1 (de) * | 1979-05-17 | 1981-04-30 | Schering Ag Berlin Und Bergkamen, 1000 Berlin | Thiazolyliden-oxo-propionitrile, insektizide mittel enthaltend diese verbindungen sowie verfahren zu ihrer herstellung |
US4346094A (en) * | 1980-09-22 | 1982-08-24 | Eli Lilly And Company | 3-Aryl-5-isothiazolecarboxylic acids and related compounds used to lower uric acid levels |
US5077305A (en) * | 1990-02-13 | 1991-12-31 | Bristol-Myers Squibb Co. | Thiazole carboxylic acids and esters |
EP0442448A3 (en) | 1990-02-13 | 1992-08-12 | Bristol-Myers Squibb Company | Heterocyclic carboxylic acids and esters |
DE10331675A1 (de) * | 2003-07-14 | 2005-02-10 | Bayer Cropscience Ag | Hetarylsubstituierte Pyrazolidindion-Derivate |
EP2959917A3 (de) * | 2007-10-19 | 2016-02-24 | The Regents of The University of California | Zusammensetzungen und verfahren zur linderung von entzündungen des zns, psychose, delirium, ptsd oder ptss |
-
1968
- 1968-03-22 GB GB03989/68A patent/GB1192701A/en not_active Expired
- 1968-03-23 BR BR207374/68A patent/BR6807374D0/pt unknown
-
1969
- 1969-02-17 US US799963A patent/US3661920A/en not_active Expired - Lifetime
- 1969-02-18 IE IE209/69A patent/IE32967B1/xx unknown
- 1969-02-23 IL IL31679A patent/IL31679A/en unknown
- 1969-02-24 CA CA043,831A patent/CA948199A/en not_active Expired
- 1969-03-14 NL NL6903963A patent/NL6903963A/xx unknown
- 1969-03-14 AT AT251269A patent/AT284841B/de not_active IP Right Cessation
- 1969-03-17 DE DE19691913472 patent/DE1913472A1/de active Pending
- 1969-03-18 CS CS809972*1A patent/CS154267B2/cs unknown
- 1969-03-18 CS CS810072*1A patent/CS154268B2/cs unknown
- 1969-03-18 CS CS193669A patent/CS154266B2/cs unknown
- 1969-03-21 CH CH806371A patent/CH553209A/de not_active IP Right Cessation
- 1969-03-21 FR FR6908408A patent/FR2004544A1/fr not_active Withdrawn
- 1969-03-21 BE BE730284D patent/BE730284A/xx unknown
- 1969-03-21 DK DK157569AA patent/DK125251B/da unknown
- 1969-03-21 CH CH434369A patent/CH513907A/de not_active IP Right Cessation
- 1969-03-22 ES ES365089A patent/ES365089A1/es not_active Expired
-
1970
- 1970-09-30 DK DK498970AA patent/DK122393B/da unknown
- 1970-09-30 DK DK498870AA patent/DK125326B/da unknown
Also Published As
Publication number | Publication date |
---|---|
FR2004544A1 (de) | 1969-11-28 |
DE1913472A1 (de) | 1969-11-06 |
CS154267B2 (de) | 1974-03-29 |
CH553209A (de) | 1974-08-30 |
DK125251B (da) | 1973-01-22 |
DK125326B (da) | 1973-02-05 |
BR6807374D0 (pt) | 1973-02-08 |
DK122393B (da) | 1972-02-28 |
GB1192701A (en) | 1970-05-20 |
IE32967B1 (en) | 1974-02-06 |
AT284841B (de) | 1970-09-25 |
NL6903963A (de) | 1969-09-24 |
US3661920A (en) | 1972-05-09 |
BE730284A (de) | 1969-09-22 |
ES365089A1 (es) | 1971-01-01 |
CS154268B2 (de) | 1974-03-29 |
IL31679A (en) | 1972-08-30 |
IE32967L (en) | 1969-09-22 |
CA948199A (en) | 1974-05-28 |
CS154266B2 (de) | 1974-03-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AT326674B (de) | Verfahren zur herstellung neuer naphthyridinderivaten | |
AT292695B (de) | Verfahren zur Herstellung neuer Isoxazolderivate | |
CH529763A (de) | Verfahren zur Herstellung neuer Hexahydrobenzazocine | |
CH513907A (de) | Verfahren zur Herstellung neuer Thiazolderivate | |
CH504426A (de) | Verfahren zur Herstellung neuer Bisnorcholanderivate | |
AT306256B (de) | Verfahren zur Herstellung neuer Benzomorphanderivate | |
CH535730A (de) | Verfahren zur Herstellung neuer Naphthylalkanole | |
AT303272B (de) | Verfahren zur Herstellung neuer Evomonosid-Derivate | |
CH517684A (de) | Verfahren zur Herstellung neuer Prostaglandinderivate | |
CH517728A (de) | Verfahren zur Herstellung neuer basisch substituierter Cumarinderivate | |
CH446340A (de) | Verfahren zur Herstellung neuer Phenthiazinderivate | |
CH498120A (de) | Verfahren zur Herstellung neuer Indenopyridinderivate | |
CH513119A (de) | Verfahren zur Herstellung neuer Halogencolchicinderivate | |
CH498817A (de) | Verfahren zur Herstellung neuer Isothiocyanato-diphenylamine | |
AT307632B (de) | Verfahren zur Herstellung neuer 18-Methyl-5α-H-androstan-derivate | |
CH537370A (de) | Verfahren zur Herstellung neuer Guanidin-Derivate | |
AT299941B (de) | Verfahren zur Herstellung neuer Thiazolderivate | |
CH497402A (de) | Verfahren zur Herstellung neuer Isothiocyanato-N-alkanoyl-diphenylamine | |
CH520703A (de) | Verfahren zur Herstellung neuer Thiazol-Derivate | |
CH511789A (de) | Verfahren zur Herstellung neuer Dichlor-trifluormethylbenzoesäuren | |
CH511227A (de) | Verfahren zur Herstellung neuer Azetidinolderivate | |
CH536297A (de) | Verfahren zur Herstellung neuer 18-Methyl-5a-H-androstane | |
CH520698A (de) | Verfahren zur Herstellung neuer Piperazinoindole | |
CH497401A (de) | Verfahren zur Herstellung neuer Isothiocyanato-N-nitroso-diphenylamine | |
AT310163B (de) | Verfahren zur Herstellung neuer Oxazol- bzw. Thiazol-Derivate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PL | Patent ceased |